Vaccination

Infectious complications of rheumatoid arthritis and psoriatic arthritis during targeted and biological therapies: a viewpoint in 2020
Olivier Lortholary, Mario Fernandez-Ruiz, John W Baddley, Oriol Manuel, Xavier Mariette, Kevin L Winthrop

Annals of the Rheumatic Diseases Dec 2020, 79 (12) 1532-1543; DOI: 10.1136/annrheumdis-2020-217092
Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
Ruth E Costello, Jenny H Humphreys, Kevin L Winthrop, William G Dixon

Annals of the Rheumatic Diseases Dec 2020, 79 (12) 1665-1666; DOI: 10.1136/annrheumdis-2020-217255
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al
Giovanni Adami, Angelo Fassio, Giovanni Orsolini, Alessandro Giollo, Davide Gatti, Maurizio Rossini

Annals of the Rheumatic Diseases Dec 2020, 79 (12) e166; DOI: 10.1136/annrheumdis-2019-215174
Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib
Kevin L Winthrop, Ann Wouters, Ernest H Choy, Connie Chen, Pinaki Biswas, Lisy Wang, Koshika Soma, Elie Needle, Hernan Valdez, William FC Rigby

Annals of the Rheumatic Diseases May 2020, 79 (5) 669-671; DOI: 10.1136/annrheumdis-2019-216566
Response to: ‘Comments on the article: "Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial"’ by Mousavi and Taherifard
Alexis Mathian, Micheline Pha, Zahir Amoura

Annals of the Rheumatic Diseases Apr 2020, annrheumdis-2020-217323; DOI: 10.1136/annrheumdis-2020-217323
IFN-α kinoid in systemic lupus erythematosus: results from a phase IIb, randomised, placebo-controlled study
Frederic A Houssiau, Aikaterini Thanou, Minodora Mazur, Edgar Ramiterre, Danny Alexis Gomez Mora, Maria Misterska-Skora, Risto Alfredo Perich-Campos, Svetlana A Smakotina, Sergio Cerpa Cruz, Bassem Louzir, Thérèse Croughs, Michael Lucas Tee

Annals of the Rheumatic Diseases Mar 2020, 79 (3) 347-355; DOI: 10.1136/annrheumdis-2019-216379
Response to: ‘Clarification regarding the statement of the association between the recombinant zoster vaccine (RZV) and gout flares’ by Didierlaurent et al
Chio Yokose, Hyon Choi

Annals of the Rheumatic Diseases Dec 2019, annrheumdis-2019-216670; DOI: 10.1136/annrheumdis-2019-216670
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
Victoria Furer, Christien Rondaan, Marloes W Heijstek, Nancy Agmon-Levin, Sander van Assen, Marc Bijl, Ferry C Breedveld, Raffaele D'Amelio, Maxime Dougados, Meliha Crnkic Kapetanovic, Jacob M van Laar, A de Thurah, Robert BM Landewé, Anna Molto, Ulf Müller-Ladner, Karen Schreiber, Leo Smolar, Jim Walker, Klaus Warnatz, Nico M Wulffraat, Ori Elkayam

Annals of the Rheumatic Diseases Jan 2020, 79 (1) 39-52; DOI: 10.1136/annrheumdis-2019-215882
Clarification regarding the statement of the association between the recombinant zoster vaccine (RZV) and gout flares
Arnaud M Didierlaurent, Christophe Desssart, Anthony L Cunningham

Annals of the Rheumatic Diseases Dec 2019, annrheumdis-2019-216639; DOI: 10.1136/annrheumdis-2019-216639
Risk of gout flares after vaccination: a prospective case cross-over study
Chio Yokose, Natalie McCormick, Clara Chen, Tuhina Neogi, Christine Chaisson, Robert Terkeltaub, David J Hunter, Yuqing Zhang, Hyon Choi

Annals of the Rheumatic Diseases Nov 2019, 78 (11) 1601-1604; DOI: 10.1136/annrheumdis-2019-215724

Main menu

Vaccination

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Vaccination

Pages